✦ LIBER ✦

Central core disease and malignant hyperthermia syndrome

✍ Scribed by John P. Frank; Yadollah Harati; Dr. Ian J. Butler; Thomas E. Nelson; Charles I. Scott

Publisher: John Wiley and Sons
Year: 1980
Tongue: English
Weight: 792 KB
Volume: 7
Category: Article
ISSN: 0364-5134
DOI: 10.1002/ana.410070105

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ryanodine receptor mutations in malignan

Ryanodine receptor mutations in malignant hyperthermia and central core disease

✍ Tommie V. McCarthy; Kathleen A. Quane; Patrick J. Lynch 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 259 KB 👁 2 views

Malignant hyperthermia (MH) is a pharmacogenetic disorder of skeletal muscle that manifests in response to anesthetic triggering agents. Central core disease (CCD) is a myopathy closely associated with MH. Both MH and CCD are primarily disorders of calcium regulation in skeletal muscle. The ryanodin

Mutations in RYR1 in malignant hyperther

Mutations in RYR1 in malignant hyperthermia and central core disease

✍ Rachel Robinson; Danielle Carpenter; Marie-Anne Shaw; Jane Halsall; Philip Hopki 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 531 KB

The RYR1 gene encodes the skeletal muscle isoform ryanodine receptor and is fundamental to the process of excitation-contraction coupling and skeletal muscle calcium homeostasis. Mapping to chromosome 19q13.2, the gene comprises 106 exons and encodes a protein of 5,038 amino acids. Mutations in the

RYR1 mutations causing central core dise

RYR1 mutations causing central core disease are associated with more severe malignant hyperthermia in vitro contracture test phenotypes

✍ Rachel L. Robinson; Collin Brooks; Sarah L. Brown; F. Richard Ellis; P. Jane Hal 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB

Malignant hyperthermia (MH) and central core disease (CCD) are autosomal dominant disorders of skeletal muscle. Susceptibility to MH is only apparent after exposure to volatile anesthetics and/or depolarizing muscle relaxants. CCD patients present with diffuse muscular weakness but are also at risk

The King syndrome: Malignant hyperthermi

The King syndrome: Malignant hyperthermia, myopathy, and multiple anomalies

✍ McPherson, Elspeth W. ;Taylor, Claude A. ;Opitz, John M. 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 333 KB

A new mutation in the skeletal ryanodine

A new mutation in the skeletal ryanodine receptor gene (RYR1) is potentially causative of malignant hyperthermia, central core disease, and severe skeletal malformation

✍ Rueffert, Henrik ;Olthoff, Derk ;Deutrich, Christine ;Schober, Ralf ;Froster, Ur 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB 👁 2 views

Dominantly inherited malignant hyperther

Dominantly inherited malignant hyperthermia (MH) in the King–Denborough Syndrome

✍ Dr. Hyam Isaacs; Margaret E. Badenhorst 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 770 KB

## Abstract A 14‐year‐old boy, an only child, with the phenotypical dysmorphic features of the King–Denborough Syndrome developed a severe hyperthermic episode during anesthesia which responded to the administration of sodium dantrolene. As adequate metabolic studies were not available at the time